APA

Robson M., Ruddy K. J., Im S., Senkus E., Xu B., Domchek S. M., Masuda N., Li W., Tung N., Armstrong A., Delaloge S., Bannister W., Goessl C., Degboe A., Hettle R. & Conte P. (20200609). Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial. : European journal of cancer (Oxford, England : 1990).

Chicago

Robson Mark, Ruddy Kathryn J, Im Seock-Ah, Senkus Elżbieta, Xu Binghe, Domchek Susan M, Masuda Norikazu, Li Wei, Tung Nadine, Armstrong Anne, Delaloge Suzette, Bannister Wendy, Goessl Carsten, Degboe Arnold, Hettle Robert and Conte Pierfranco. 20200609. Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial. : European journal of cancer (Oxford, England : 1990).

Harvard

Robson M., Ruddy K. J., Im S., Senkus E., Xu B., Domchek S. M., Masuda N., Li W., Tung N., Armstrong A., Delaloge S., Bannister W., Goessl C., Degboe A., Hettle R. and Conte P. (20200609). Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial. : European journal of cancer (Oxford, England : 1990).

MLA

Robson Mark, Ruddy Kathryn J, Im Seock-Ah, Senkus Elżbieta, Xu Binghe, Domchek Susan M, Masuda Norikazu, Li Wei, Tung Nadine, Armstrong Anne, Delaloge Suzette, Bannister Wendy, Goessl Carsten, Degboe Arnold, Hettle Robert and Conte Pierfranco. Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial. : European journal of cancer (Oxford, England : 1990). 20200609.